TQH3906 capsule Clinical Trials

2 actively recruiting trials

▲ +1 trial since July 2026

Pipeline

Phase 2: 2

Top Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Indications

Systemic Lupus Erythematosus1
Psoriatic Arthritis1
Lupus1
Arthritis1

Other2 trials

A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis

Phase 2

A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.